Search results
Joe Biden calls US allies India and Japan 'xenophobic'
BBC via AOL· 31 minutes agoThe comments, however, have drawn criticism from US commentators. On X, formerly Twitter, Elbridge...
Dow Jones Futures Rise As Stock Market Rallies Into Jobs Report; Apple Jumps On Buyback
Investor's Business Daily· 4 minutes agoSo have your exit plans in place. Read The Big Picture every day to stay in sync with the market...
Apple earnings results: Tim Cook announces biggest-ever stock buyback of $110 billion as sales and...
Business Insider· 6 hours agoApple reported fiscal Q2 earnings that beat on sales and EPS, and did better than expected in China....
Irish services sector growth slows in April, PMI shows
Reuters· 2 hours agoThe AIB S&P Global Purchasing Managers' Index (PMI) was 53.3 in April, down from 56.6 in March,...
Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
Investor's Business Daily· 6 hours agoFor the year, Novo Nordisk expects sales to climb 19% to 27% in constant currency. The company also...
Coinbase Delivers Major Earnings, Revenue Beat Thanks To Soaring Bitcoin Prices, Crypto Interest
Investor's Business Daily· 5 hours agoThe U.S. spot bitcoin ETFs, including the iShares Bitcoin Trust, ARK 21Shares Bitcoin ETF and...
IBD 50 Electrical Stock Retreats After Earnings Jolt
Investor's Business Daily· 11 hours agoRevenue growth is on a similar trajectory, with a 15% increase expected in its current quarter, then 11% and 10% in the next two periods. Fiscal...
Lee Enterprises reports strong digital subscription growth in second quarter
Quad-City Times· 7 hours agoDigital subscriptions are up 25% over the year prior and digital-only subscription revenue grew 48%...
Is Tesla Stock A Buy Or A Sell With Shares Rallying 20% Since Q1 Earnings?
Investor's Business Daily· 6 hours agoElon Musk, Growth And Layoffs Musk decided to let two top executives go while also cutting the EV...
Amgen Is 'Very Encouraged' With Its Obesity Study; Shares Rocket 13%
Investor's Business Daily· 4 hours agoThe best growth came from Tezspire, Amgen's treatment for severe asthma. Sales skyrocketed 80% to...